
EuroPCR 2023: Improving outcomes in mitral regurgitation
Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.
Related Videos

EuroPCR 2023: COAPT 5-year follow-up

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

TAVI 2023: The next level

Luca's testimonial

Epic™ HCP testimonial

Now you've got Navitor.
Future ready.

AV VALVES 2023: MR – Acute Rupture

Navitor™: Voice of the Experts Federico de Marco

AV VALVES 2023: MR – Mixed MR

TriClip™ G4: Animation